Figure 5From: Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against Influenza A M2 proteinEffect of M2-specific antibody D005 on Influenza-induced morbidity and mortality. Mice were treated with 144 μg scFv-msFc-γ2c, 200 μg hIgG1 or 200 μg control human IgG (Ctr. Ab) on day -2, infected with Influenza A virus PR8 on day 0, and body temperature (A), weight (B) and survival (C) were monitored on the indicated days.Back to article page